Bullous pemphigoid complicating human orf disease
DOI:
https://doi.org/10.66344/jpad.28.3.2018.1104Keywords:
Orf, bullous pemphigoid, orf-induced immunobullous diseaseAbstract
Orf is a zoonosis caused by Parapoxvirus and transmitted to human by sheep. Bullous pemphigoid has been reported as an occasional complication following orf. We report a 51-year-old female who developed bullous pemphigoid 3 weeks following orf. The case is reported for its rare co-occurrenceReferences
Ozturk, P., Sayar, H., Karakas, T., & Akman, Y: Erythema multiforme as a result of orf
disease. Acta dermatovenerologica Alpina, Pannonica, et Adriatica 2012; 21(2), 45.
Shahmoradi, Z., Abtahi-Naeini, B., Pourazizi, M., & Meidani, M: Orf disease following
“Eid ul-Adhaâ€.A rare cause of erythema multiforme. International journal of preventive
medicine 2014; 5(7), 912.
Agger, W. A., & Webster, S. B: Human orf infection complicated by erythema
multiforme. Cutis 2014; 31(3), 334-338.
Alian, S., Ahangarkani, F., & Arabsheybani, S: A case of orf disease complicated with
erythema multiforme and bullous pemphigoid-like eruptions. Case reports in infectious
diseases, 2015.
White, K. P., Zedek, D. C., White, W. L., Simpson, E. L., et al :Orf-induced immunobullous
disease: A distinct autoimmune blistering disorder. Journal of the American Academy of
Dermatology 2008;58(1), 49-55.
Murphy, J. K., & Ralfs, I. G:Bullous pemphigoid complicating human orf. British
Journal of Dermatology 2008; 134(5), 929-930.
Van Lingen, R. G., Frank, R. G. J., Koopman, R. J. J., & Jonkman, M. F: Human orf
complicated by mucous membrane pemphigoid. Clinical and experimental dermatology
; 31(5), 711-712.
Avcı, A., Avcı, D., Turasan, A., & Çınar, S. L; Orfun İndüklediği Büllöz Pemfigoid
Olgusu. Turkish Journal of Dermatology 2013;7(2).
Downloads
Published
How to Cite
Issue
Section
License
Submission declaration
Authors retain the copyright to their work and grant the 'Journal of Pakistan Association of Dermatologists (JPAD)' the right of first publication under a Creative Commons Attribution 4.0 International (CC BY 4.0) license. This license allows others to share, adapt, and reuse the work for any purpose, including commercial use, as long as appropriate credit is given to the original authors and the journal.
By submitting a manuscript, authors confirm that the work has not been published previously (except as an abstract, lecture, or academic thesis), is not under review elsewhere, and has been approved by all authors and relevant authorities. Once accepted, the article will be openly accessible under the CC BY 4.0 license, ensuring wide dissemination and reuse with proper attribution.